永泰生物-B(06978) - 最新股东
*注解:(L)- 好仓, (S)- 淡仓, (P)- 可供借出的股份。
全部董事非董事
股东名称 | 持有权益的股份数目 | 占已发行的有投票权股份百分比 | 占股本比例 | 最后申报有关通知之日期 | 表格序号 |
---|---|---|---|---|---|
China Resources Company Limited | 42.18% | 2024-08-04 | CS20240807E00303 | ||
吴迺峰 | 37.23% | 2023-03-31 | IS20230406E00578 | ||
李畇慧 | 37.23% | 2023-03-31 | IS20230406E00593 | ||
闫凯境 | 37.23% | 2023-03-31 | IS20230406E00588 | ||
闫希军 | 37.23% | 2023-03-31 | IS20230406E00601 | ||
譚錚 (董事) | 36.04% | 2023-02-20 | DA20230301E00315 | ||
華潤三九醫藥股份有限公司China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 32.18% | 2024-08-04 | CS20240807E00299 | ||
譚曉陽 | 11.62% | 2020-07-10 | IS20200723E00064 | ||
譚月月 | 11.62% | 2023-02-20 | IS20230301E00317 | ||
張軍政 | 8.72% | 2022-01-15 | IS20220413E00436 | ||
王敏慧 | 8.72% | 2022-01-15 | IS20220413E00431 | ||
鄭鉉哲 (董事) | 8.71% | 2023-04-11 | DA20230411E00480 | ||
Greater Bay Area Homeland Investments Limited | 6.44% | 2020-07-10 | CS20200723E00261 | ||
王歈 (董事) | 4.56% | 2020-08-05 | DA20200806E00040 |